标题/作者	年份
Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane L Chiaradia, C Lefebvre, J Parra, J Marcoux, O Burlet-Schiltz, G Etienne, ... Scientific reports 7 (1), 12807	2017
Mycobacterium abscessus: environmental bacterium turned clinical nightmare RC Lopeman, J Harrison, M Desai, JAG Cox Microorganisms 7 (3), 90	2019
Extracellular vesicle biogenesis and functions in gram-positive bacteria P Briaud, RK Carroll Infection and immunity 88 (12), 10.1128/iai. 00433-20	2020
New tuberculosis drug targets, their inhibitors, and potential therapeutic impact GS Shetye, SG Franzblau, S Cho Translational Research 220, 68-97	2020
Cell wall: a versatile fountain of drug targets in Mycobacterium tuberculosis ZS Bhat, MA Rather, M Maqbool, HUL Lah, SK Yousuf, Z Ahmad Biomedicine & Pharmacotherapy 95, 1520-1534	2017
Adsorption of bacteriophages on bacterial cells AV Letarov, EE Kulikov Biochemistry (Moscow) 82, 1632-1658	2017
Unraveling the structure of the mycobacterial envelope M Daffé, H Marrakchi Microbiology spectrum 7 (4), 7.4. 1	2019
Promiscuous targets for antitubercular drug discovery: The paradigm of DprE1 and MmpL3 G Degiacomi, JM Belardinelli, MR Pasca, E De Rossi, G Riccardi, ... Applied Sciences 10 (2), 623	2020
Arrayed CRISPRi and quantitative imaging describe the morphotypic landscape of essential mycobacterial genes TJ de Wet, KR Winkler, M Mhlanga, V Mizrahi, DF Warner Elife 9, e60083	2020
Tuberculosis drug discovery: challenges and new horizons GFS Fernandes, AM Thompson, D Castagnolo, WA Denny, ... Journal of Medicinal Chemistry 65 (11), 7489-7531	2022
Tuberculosis drug discovery: A decade of hit assessment for defined targets S Oh, L Trifonov, VD Yadav, CE Barry III, HI Boshoff Frontiers in Cellular and Infection Microbiology 11, 611304	2021
Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon ZS Bhat, MA Rather, M Maqbool, Z Ahmad Biomedicine & Pharmacotherapy 103, 1733-1747	2018
Mycobacterial cell wall: a source of successful targets for old and new drugs C Vilchèze Applied Sciences 10 (7), 2278	2020
Cryo-EM structures and regulation of arabinofuranosyltransferase AftD from mycobacteria YZ Tan, L Zhang, J Rodrigues, RB Zheng, SI Giacometti, AL Rosário, ... Molecular cell 78 (4), 683-699. e11	2020
Revisiting anti-tuberculosis therapeutic strategies that target the peptidoglycan structure and synthesis MJ Catalão, SR Filipe, M Pimentel Frontiers in Microbiology, 190	2019
Ultrastructural analysis of cell envelope and accumulation of lipid inclusions in clinical Mycobacterium tuberculosis isolates from sputum, oxidative stress, and iron deficiency S Vijay, HT Hai, DDA Thu, E Johnson, A Pielach, NH Phu, GE Thwaites, ... Frontiers in Microbiology 8, 2681	2018
Bioenergetic inhibitors: antibiotic efficacy and mechanisms of action in Mycobacterium tuberculosis EJ Hasenoehrl, TJ Wiggins, M Berney Frontiers in cellular and infection microbiology, 815	2021
Synthesis and recycling of the mycobacterial cell envelope KA Abrahams, GS Besra Current Opinion in Microbiology 60, 58-65	2021
Phospholipid homeostasis, membrane tenacity and survival of Mtb in lipid rich conditions is determined by MmpL11 function A Bothra, P Arumugam, V Panchal, D Menon, S Srivastava, D Shankaran, ... Scientific reports 8 (1), 8317	2018
Mycobacterium tuberculosis metabolism GT Mashabela, TJ De Wet, DF Warner Microbiology spectrum 7 (4), 7.4. 18	2019

1 - 20

计算机程序会自动估算并确定日期和引用次数。